Eli Lilly, Novo Nordisk near deals with Trump admin to cut weight loss drug prices

0
117

Eli Lilly and Novo Nordisk, whose weight loss-related drugs have created a frenzy, are working with the Trump administration on a deal that would cut the cost of the lowest doses of their popular drugs to $149 for a month’s supply, sources familiar with the matter told The Wall Street Journal. 

As part of the deal, which could be announced as soon as Thursday, the drugs would be sold through TrumpRx, a forthcoming government-run initiative expected to launch next year that will connect consumers directly with drug manufacturers to purchase discounted prescription drugs without insurance.

Under the deal, Medicare and Medicaid would also cover the drugs for weight loss, effectively boosting the number of patients who can access the drug, the sources…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here